Clear all
Coverage since November 3, 1994

Federal Circuit

Uncategorized

Abbott Laboratories v. Sandoz — Federal Circuit En Banc Clarifies Preliminary Injunction Standards for Pharmaceutical Patents

The Federal Circuit en banc held that the traditional four-factor preliminary injunction test applies in Hatch-Waxman patent cases — eliminating the prior practice under which a showing of validity and infringement created a presumption of irreparable harm — and remanded the preliminary injunction a

Uncategorized

Sanofi-Synthelabo v. Apotex — Federal Circuit Upholds Plavix Patent, Holds Racemic Mixture Does Not Anticipate Isolated Enantiomer

The Federal Circuit affirmed the validity of Sanofi’s Plavix (clopidogrel) patent, holding that prior disclosure of a racemic mixture does not anticipate a claim to an isolated single enantiomer — particularly when the enantiomer exhibits unexpectedly superior properties not predictable from t

Scroll to Top